Total Payments
$5,141
2024 Payments
$400.44
Companies
30
Transactions
262
Medicare Patients
3,194
Medicare Billing
$320,180
Payment Breakdown by Category
Food & Beverage$4,119 (80.1%)
Other$552.71 (10.8%)
Education$469.74 (9.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,119 | 249 | 80.1% |
| Honoraria | $527.00 | 1 | 10.3% |
| Education | $469.74 | 10 | 9.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.71 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,826 | 132 | $0 (2021) |
| ABBVIE INC. | $592.20 | 36 | $0 (2024) |
| Genentech USA, Inc. | $563.19 | 9 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $255.97 | 7 | $0 (2022) |
| Biogen, Inc. | $245.90 | 8 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $206.88 | 5 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $193.50 | 11 | $0 (2021) |
| Amgen Inc. | $187.44 | 14 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $151.80 | 3 | $0 (2021) |
| PFIZER INC. | $129.67 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $400.44 | 21 | ABBVIE INC. ($247.49) |
| 2023 | $219.58 | 15 | AbbVie Inc. ($156.42) |
| 2022 | $344.36 | 11 | ABBVIE INC. ($160.41) |
| 2021 | $654.86 | 32 | Biohaven Pharmaceuticals, Inc. ($206.88) |
| 2020 | $491.44 | 40 | Teva Pharmaceuticals USA, Inc. ($242.28) |
| 2019 | $971.63 | 55 | Teva Pharmaceuticals USA, Inc. ($263.79) |
| 2018 | $1,185 | 47 | Teva Pharmaceuticals USA, Inc. ($856.74) |
| 2017 | $874.00 | 41 | Teva Pharmaceuticals USA, Inc. ($446.41) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Pain Management | ||||||
| 08/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 06/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: PAIN | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: Immunology and Neurology | ||||||
| 03/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 03/29/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PAIN | ||||||
| 10/24/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Genentech, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $46.75 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 728 | 925 | $304,763 | $75,683 |
| 2022 | 10 | 776 | 948 | $307,490 | $79,708 |
| 2021 | 9 | 858 | 1,095 | $277,087 | $88,269 |
| 2020 | 9 | 832 | 1,075 | $249,130 | $76,521 |
Total Patients
3,194
Total Services
4,043
Medicare Billing
$320,180
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 307 | $65,084 | $25,984 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 272 | 335 | $47,905 | $19,004 | 39.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 77 | 106 | $84,270 | $7,305 | 8.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 56 | $16,352 | $6,822 | 41.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 28 | 28 | $37,968 | $5,157 | 13.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $10,600 | $3,756 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 34 | $11,322 | $3,709 | 32.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 22 | 22 | $19,118 | $2,754 | 14.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 12 | 12 | $12,144 | $1,191 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 327 | $69,324 | $27,436 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 233 | 293 | $41,899 | $15,825 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 65 | 77 | $22,484 | $9,274 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $22,644 | $6,980 | 30.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 73 | 88 | $69,960 | $6,363 | 9.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $12,296 | $4,711 | 38.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 28 | 28 | $24,332 | $3,484 | 14.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 15 | 15 | $20,340 | $2,724 | 13.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $12,067 | $1,780 | 14.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 12 | 12 | $12,144 | $1,132 | 9.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 356 | 515 | $73,645 | $29,537 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 253 | $53,636 | $21,602 | 40.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 130 | 130 | $43,290 | $15,131 | 35.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 61 | 83 | $36,137 | $6,149 | 17.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 46 | $13,432 | $6,047 | 45.0% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 17 | 17 | $23,052 | $3,286 | 14.3% |
About Dr. David Blake, MD
Dr. David Blake, MD is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295837094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Blake, MD has received a total of $5,141 in payments from pharmaceutical and medical device companies, with $400.44 received in 2024. These payments were reported across 262 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,119).
As a Medicare-enrolled provider, Blake has provided services to 3,194 Medicare beneficiaries, totaling 4,043 services with total Medicare billing of $320,180. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lexington, KY
- Active Since 09/02/2006
- Last Updated 05/22/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1295837094
Products in Payments
- COPAXONE (Drug) $909.91
- AJOVY (Drug) $447.58
- QULIPTA (Drug) $353.49
- UBRELVY (Drug) $261.84
- AJOVY (Biological) $258.94
- NURTEC ODT (Drug) $258.90
- Aimovig (Biological) $187.44
- OCREVUS (Biological) $175.20
- ZEPOSIA (Drug) $173.43
- TYSABRI (Biological) $171.48
- NUPLAZID (Drug) $151.80
- Activase (Biological) $110.74
- Briviact (Drug) $97.85
- AIMOVIG (Biological) $84.84
- MAYZENT (Drug) $80.74
- ELIQUIS (Drug) $77.65
- Rebif (Biological) $73.49
- Reveal LINQ (Device) $63.62
- Ponvory (Drug) $60.00
- AUSTEDO (Drug) $52.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Neurology $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Neurology $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Neurology $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Neurology $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Neurology $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615
Neurology $19,615